Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lakeshore Biopharma Ltd (LSB)

Lakeshore Biopharma Ltd (LSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lakeshore Biopharma Ltd BUILDING NO. 2 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT BEIJING F4 102629 CHN

www.ysbiopharm.com P: 010-892-0208

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

LakeShore Biopharma is a biopharmaceutical company. It involved in discovering, developing, manufacturing and delivering vaccines and therapeutic biologics for infectious diseases and cancer. The company operates primarily in China, the United States, Singapore and the Philippines. LakeShore Biopharma, formerly known as YS Biopharma, is based in GAITHERSBURG, Md.

Key Statistics

Overview:

Market Capitalization, $K 13,021
Enterprise Value, $K 55,711
Shares Outstanding, K 20,767
Float, K 20,767
% Float 100.00%
Short Interest, K 18
Days to Cover 1.00
Short Volume Ratio 0.34
% of Institutional Shareholders 52.64%

Financials:

Annual Sales, $ 85,670 K
Annual Net Income, $ -13,930 K
Last Quarter Sales, $ 23,820 K
Last Quarter Net Income, $ -11,550 K
EBIT, $ -10,280 K
EBITDA, $ -6,910 K

Growth:

1-Year Return -91.58%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 10/30/25
Earnings Per Share ttm -1.60
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 10/04/24

LSB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -16.26%
Debt/Equity 0.83
Price/Sales 0.19
Price/Cash Flow N/A
Price/Book 0.19
Book Value/Share 3.35
Interest Coverage -5.42
60-Month Beta 0.56
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar